GRI Bio, Inc.
GRI
$1.98
$0.031.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.02% | -0.28% | -40.32% | -45.17% | -50.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | 100.00% |
| Total Operating Expenses | 35.62% | 19.90% | -22.02% | -26.05% | -22.92% |
| Operating Income | -35.62% | -19.90% | 22.02% | 26.05% | 22.92% |
| Income Before Tax | -82.77% | -67.53% | -3.54% | 7.44% | 37.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -82.77% | -67.53% | -3.54% | 7.44% | 37.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -82.77% | -67.53% | -3.54% | 7.44% | 37.87% |
| EBIT | -35.62% | -19.90% | 22.02% | 26.05% | 22.92% |
| EBITDA | -35.63% | -19.91% | 22.03% | 26.06% | 22.93% |
| EPS Basic | 94.46% | 93.42% | 81.03% | 61.74% | 41.18% |
| Normalized Basic EPS | 92.91% | 86.19% | 17.87% | -- | -- |
| EPS Diluted | 91.78% | 91.46% | 79.32% | 60.09% | 41.18% |
| Normalized Diluted EPS | 92.91% | 86.19% | 17.87% | -- | -- |
| Average Basic Shares Outstanding | 2,324.48% | 6,084.03% | 6,524.06% | -- | -- |
| Average Diluted Shares Outstanding | 2,155.11% | 3,632.09% | 1,596.85% | 911.05% | 268.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |